Skip to main content
MAZE logo
MAZE
(NASDAQ)
Maze Therapeutics, Inc.
$28.71-- (--)
Loading... - Market loading

Maze Therapeutics (MAZE) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Maze Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Maze Therapeutics, Inc. (MAZE) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2024FY 2023FY 2022
Period EndingDec 2025Mar 2025Dec 2024Dec 2023Dec 2022
Current Assets
Cash and Cash Equivalents189.25196.81196.8129.1699.92
Short-Term Investments152.670.000.000.000.00
Cash & Short-Term Investments341.92196.81196.8129.1699.92
Accounts Receivable0.000.000.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets7.804.864.864.956.23
Total Current Assets349.72201.67201.6734.11106.15
Non-Current Assets
Property, Plant & Equipment (Net)25.1629.9229.9234.9841.23
Long-Term Investments0.001.090.001.091.21
Other Non-Current Assets4.147.874.351.322.58
Total Non-Current Assets47.4138.8738.8737.3943.81
Total Assets397.13240.54240.5471.50149.96
Current Liabilities
Accounts Payable1.791.941.942.021.59
Short-Term Debt0.004.630.004.494.32
Accrued Liabilities5.110.0014.109.817.49
Other Current Liabilities0.0014.100.009.8114.87
Total Current Liabilities22.5620.6720.6716.3220.78
Non-Current Liabilities
Long-Term Debt18.5122.0022.0045.1327.73
Other Non-Current Liabilities1.090.970.970.000.00
Total Non-Current Liabilities19.6122.97531.0545.13411.63
Total Liabilities42.1643.6443.6461.45432.42
Stockholders' Equity
Common Stock0.050.000.000.020.00
Retained Earnings-489.55-358.43-358.43-395.69-295.27
Accumulated Other Comprehensive Income0.110.000.000.000.00
Additional Paid-in Capital844.3547.2447.2421.8212.81
Shares Outstanding49.340.0043.7843.7843.78
Total Stockholders' Equity354.97196.90-311.1810.05-282.46
Total Liabilities & Equity397.13240.54240.5471.50149.96

Frequently Asked Questions About Maze Therapeutics Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is MAZE's debt level?

Review Maze Therapeutics's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.